Part No: P149Issued year: 2016File size: 0.12mbFile type: pdf
With the de-criminalization of recreational cannabis, containing the hallucinogen THC, and other cannabinoids with purported medicinal value, e.g. CBD (Figure 1), in several states a need for higher purity “products” has become a necessity. Current technology uses extraction with supercritical fluids or other non-supercritical solvents to remove the products of interest from other endogenous species such as lipids, terpenes, and chlorophylls as well as pesticides.
These techniques help clean up raw extracts and isolate cannabinoids with higher-purity but not to the levels desired by many producers so there is a developing need for a secondary purification step.
Part No: PPS376Issued year: 2015File size: 1.6mbFile type: pdf
User Case: Kissei Pharmaceutical Co., Ltd. One of Japan’s innovative pharmaceutical companies uses Isolera™ flash
purification systems and Biotage® Initiator+ microwave synthesizers in the
development of new prescription drugs. Modern lab instruments contribute to
efficient use of time and resources at Kissei Pharmaceuticals.
Part No: P143Issued year: 2016File size: 0.27mbFile type: pdf
Buprenorphine and Norbuprenorphine are typically problematic for analysis due to analyte stability issues during sample preparation.
This poster will demonstrate two fast and robust methods for the extraction of buprenorphine and norbuprenorphine in urine (using EVOLUTE EXPRESS CX), oral fluid (using EVOLUTE EXPRESS CX) and whole blood (using ISOLUTE SLE+).
Part No: PN43Issued year: 2011File size: 0.27mbFile type: pdf
Endogenous phospholipids present in biological fluids are a major problem in LCMS/ MS analysis as they are often very difficult to remove during sample preparation. When phospholipids are not removed, they retain very strongly on reversed phase analytical columns. If high organic (end of run) washes are not incorporated into the LC methods these matrix components may elute in subsequent analyses causing regions of suppression/enhancement leading to inaccurate quantitation. This poster evaluates the use of polymer-based solid phase extraction (SPE) sorbents, incorporating hydrophobic and various mixedmode retention mechanisms to address the problems associated with phospholipid removal.
Phospholipid, EVOLUTE, STRATA X, OASIS, WATERS, AX, WAX, CX, WCX, ABN, ASMS 2011
Part No: P078Issued year: 2014File size: 0.25mbFile type: pdf
This poster focuses on the different strategies that can be employed when using EVOLUTE SPE sorbents (with both single and dual retention mechanisms) to reduce or eliminate residual phospholipids in sample extracts.
Part No: P032Issued year: 2011File size: 1.35mbFile type: pdf
Endogenous phospholipids (outline structure shown in
Figure 1.) present in biological fluids are a major problem
in LC-MS/MS analysis. Due to their strong retention
characteristics in reversed phase chromatography
phospholipids tend not to elute as discrete peaks and are
often very difficult to separate from analytes of interest.
This co-elution often leads to areas of suppression or enhancement in the chromatogram which in turn can cause
quantitation issues. Supported liquid extraction (SLE) is an
analogous technique to traditional liquidliquid
extraction. This poster compares phospholipid removal using a wide variety of solvent combinations, pH control and polar extraction solvents on supported liquid extraction plates
Part No: Issued year: 2011File size: 1.65mbFile type: pdf
User Report: Syro I, University of Tokyo. The Suga Laboratory at RCAST, University of Tokyo, uses the Biotage Syro I automated peptide synthesizer for scaling up the chemical synthesis of non-standard peptides.
Part No: 412941-DIssued year: 2012File size: 1.18mbFile type: pdf
ELSD-1080 (evaporative light-scattering detector) is a
universal detector designed for use with Isolera One
and Isolera Four systems when purifying compounds
with little or no UV absorption such as carbohydrates,
steroids, lipids, and terpenes
Part No: AN084Issued year: 2014File size: 0.86mbFile type: pdf
This application note outlines how to use the Isolera system to perform a size-exclusion separation as part of a sample clean up method defined by the EPA, a key sample preparation step in environmental laboratories.
Part No: AN005-HORIssued year: 2009File size: 0.8mbFile type: pdf
EPA Method 506 is used to determine Phthalate and Adipate Esters in drinking water. The analytes are extracted from water using a Horizon Technology 47 mm Atlantic C18 disk. The disk is extracted with Acetonitrile and Methylene Chloride. The extract is then dried and concentrated to a final volume of 1.0 mL using the Horizon Technology DryVap® with DryDisk® technology. Final analysis is by GC/PID.
Part No: AN006-HORIssued year: 2009File size: 0.8mbFile type: pdf
Method 508.1 is used to determine twenty-nine chlorinated
pesticides, three herbicides, and four organohalides in
ground water, drinking water, and water in any treatment
stage. The analytes are extracted from the water using a 47
mm C18 disk. The disk is extracted on the Horizon
Technology SPE-DEX® 4790 Automated Extraction
System using Ethyl Acetate and Methylene Chloride
(DCM). The extract is then dried and concentrated using
the Horizon Technology DryVap® with DryDisk®
technology. Final analysis is by GC/ECD.
Part No: AN010-HORIssued year: 2009File size: 0.8mbFile type: pdf
Method 526 is a gas chromatography / mass spectrometry(GC/MS) method for the determination of selected semivolatile compounds in raw and finished drinking waters.This method efficiently extracts analytes using the SPEDEX® 4790 with an Atlantic® 47 mm polystyrene divinylbenzene (DVB) disk. The disk is extracted with using Ethyl Acetate (EtAc) and Methylene Chloride (DCM). The extract is then dried and concentrated using the DryVap® concentrator system coupled with DryDisk® technology to a final volume of 1.0 mL. Final analysis is done by GC/MS.
Part No: AN013-HORIssued year: File size: 0.74mbFile type: pdf
EPA Method 548.1 details the procedure for the determination of endothall in drinking water by ionexchange solid phase extraction (SPE), acidic methanol methylation, and gas chromatography / mass spectrometry.
This note presents data from the State of Idaho Bureau of Labs for the initial demonstration of capability using the Biotage® Horizon T4790 Automated Extractor System.
Part No: AN015-HORIssued year: File size: 0.79mbFile type: pdf
EPA Method 552.1 is an ion exchange procedure used for determining haloacetic acids and dalapon in drinking water and drinking water sources.
The purpose of this application note is to present data demonstrating the capability of the Horizon Technology SPE-DEX® 4790 Automated Extraction System to perform the sample extraction required for this method.
Part No: P128Issued year: 2015File size: 0.26mbFile type: pdf
In all areas of analytical laboratory testing it is vital to ensure proper quality measures are in place to reduce or eliminate cross contamination between samples, which could result in false positive and/or false negative results. In many cases sample carryover in the LC/MS system is checked early on in the method development process. However, one area that can often be overlooked the sample preparation stage. This involves all aspects including pipetting, sample transfer, extraction protocol, evaporation and mixing steps. This poster examines various stages of the sample preparation process to determine the potential for cross contamination and present approaches to minimize and or eliminate the effect. This is demonstrated via a series of dye experiments combined with analyte testing using LC-MS/MS.
Part No: P126Issued year: 2015File size: 0.48mbFile type: pdf
This poster demonstrates the use of a novel protein and phospholipid depletion plate, for the extraction of 25-hydroxy vitamin D from serum. The extraction protocol was ultimately transferred to an SPE automation platform and method performance versus manual processing was compared.
Part No: P079Issued year: 2014File size: 0.59mbFile type: pdf
The new ISOLUTE® PLD+ Protein and Phospholipid Removal Plate is highlighted in this poster. Protein and phospholipid removal, and analyte recovery are included, along with data illustrating the positive impact of clean (PL and protein free) samples in maintaining analyte signal intensity and low UPLC column back pressure over multiple LCMS runs.
Part No: P088Issued year: 2014File size: 1.06mbFile type: pdf
This poster evaluates the performance of a novel 96-well filter plate (ISOLUTE PLD+ Protein and Phospholipid Removal Plate) for
the simultaneous removal of proteins and phospholipids from serum samples prior to LC-MS/MS analysis.
Part No: P104Issued year: 2014File size: 0.77mbFile type: pdf
This poster presents the ISOLUTE PLD+ Protein and Phospholipid removal plate, highlighting its ease of use and excellent performance with respect to sample clean up, analyte recovery and elimination of back pressure build up in the UPLC system.
Part No: P153Issued year: 2016File size: 0.52mbFile type: pdf
In postmortem cases, where drugs or pesticides have been used for
their poisonous properties, traditional matrices such as urine and
whole blood may be inappropriate for qualitative and quantitative
analysis. As the site of metabolism for most drugs and toxins, the
liver may provide more insight to cause of death than other bodily
This poster describes the use of ISOLUTE SLE+ supported liquid extraction columns to extract a range of drug and pesticide classes form homogenised liver using a simple, streamlined workflow.
Part No: P112Issued year: 2014File size: 1.4mbFile type: pdf
This poster demonstrates the extraction of a range of drugs of abuse from oral fluid, collected with common collection devices, prior to UPLC-MS/MS analysis. The target analyte list includes benzodiazepines, z drugs, amphetamines, cathinones, opiates, cocaine, buprenorphine, PCP, THC-COOH, fentanyl and ketamine.
Part No: P132Issued year: 2015File size: 1.55mbFile type: pdf
This poster demonstrates the extraction of a range of drugs of abuse from oral fluid collection devices using supported liquid extraction suitable for UPLC-MS/MS analysis. Unlike some sample preparation techniques, SLE allows for the simultaneous extraction of cross-functional analytes in a single extraction protocol without forfeiting extract cleanliness.
The target analyte list includes benzodiazepines, z drugs, amphetamines, cathinones, opiates, cocaine, buprenorphine, PCP, THC-COOH, fentanyl and ketamine.
Part No: P087Issued year: 2014File size: 0.94mbFile type: pdf
This poster describes the extraction of a range of drugs of abuse (including barbiturates, THC and metabolites, benzodiazepines, z drugs, amphetamines,cathinones, opiates, cocaine, buprenorphine, PCP, fentanyl and ketamine) from oral fluid using supported liquid extraction (ISOLUTE SLE+) columns prior to GC-MS and LC-MS/MS analysis.
Part No: P138Issued year: 2015File size: 0.82mbFile type: pdf
This poster demonstrates a fast, reliable protocol to extract multiple drug of abuse panels from whole blood using a common supported liquid extraction methodology. This benefits laboratory workflow where multiple assays are run each day, saving both worker hours and
Part No: P026Issued year: 2008File size: 0.36mbFile type: pdf
Matrix components, particularly salts, proteins and
phospholipids, can lead to ion suppression resulting in
inaccurate quantitation and reduced detection limits.
Resin-based mixed-mode cation exchange SPE sorbents
are widely used for the extraction of basic compounds
from biological fluids. The dual retention mechanism
allows a two stage interference wash protocol, which
results in extremely clean extracts.
This poster will investigate the performance of
EVOLUTE™ CX for the extraction of a wide range of basic
drugs from plasma, showing high analyte recovery and
advanced extract cleanliness. The analyte suite was
selected to cover a variety of basic analytes with wide
ranging polarities (LogP values). Extract cleanliness
experiments were performed showing overall ion
suppression, then individual matrix components examined
in terms of protein and phospholipid removal.
Part No: P129Issued year: 2015File size: 0.57mbFile type: pdf
Methylisothiazolinone (MI) is used in a variety of personal care products, such as sunscreens, lotions, cosmetics. MI is a cytotoxin and as a result there is concern because of sensitization and allergic reactions as well as cell and nerve damage. A percentage of the population is at risk from contact dermatitis when exposed to this compound at sufficient concentrations. This poster describes the use of ISOLUTE SLE+ for extraction of MI from sunscreen.
Part No: P151Issued year: 2016File size: 0.96mbFile type: pdf
This poster compares the performance of manual processing to a novel automated sample preparation system prior to GC/MS or LC-MS/MS analysis in forensic toxicology applications. Emphasis is placed on the potential for 96-well cross contamination and strategies for its elimination.
Part No: P025Issued year: 2008File size: 0.35mbFile type: pdf
Matrix components, particularly salts, proteins and phospholipids, can lead to ion suppression resulting in inaccurate quantitation and reduced detection limits.
Resin-based mixed-mode cation exchange SPE sorbents are widely used for the extraction of basic compounds from biological fluids. The dual retention mechanism allows a two stage interference wash protocol, which results in extremely clean extracts. This poster will investigate the performance of EVOLUTE™ CX for the extraction of a wide range of basic
drugs from plasma, showing high analyte recovery and advanced extract cleanliness. The analyte suite was selected to cover a variety of basic analytes with wide ranging polarities (LogP values). Extract cleanliness experiments were performed showing overall ion suppression, then individual matrix components examined
in terms of protein and phospholipid removal.
Part No: P184Issued year: 2018File size: 0.56mbFile type: pdf
Traditionally the analysis of aldosterone and angiotensin (for plasma renin activity measurement) are performed separately. However, the relationship of the aldosterone-to-renin-ratio is a very useful tool to help define the cause of secondary hypertension. This poster compares sample preparation options for the simultaneous extraction of Angiotensin I, II and Aldosterone from plasma.
Part No: P147Issued year: 2016File size: 0.27mbFile type: pdf
For as long as column chromatography has been practiced by
organic and medicinal chemists there has been a concern that too
much methanol in the solvent system will dissolve the column’s
silica. This concern has come about because chemists often find a
solid white precipitate in collected fractions after purification. This
phenomenon is usually noticed when dichloromethane and
methanol are used as the mobile phase solvents.
In this poster we will show the results of a study that evaluated the
degree of dissolution for both granular and spherical silica in
methanol and dichloromethane.
Part No: P045Issued year: 2012File size: 0.32mbFile type: pdf
This poster will demonstrate SPE sample preparation strategies for the simultaneous extraction of both ethyl glucuronide and ethyl sulphate from urine, allowing cleaner extraction protocols compared to traditional dilute and shoot approaches.
EtG, EtS, Urine, Poster, SOFT, Forensic, UPLC, LC-MS/MS, EVOLUTE, AX, WAX
Part No: P127Issued year: 2015File size: 0.17mbFile type: pdf
EVOLUTE® EXPRESS SPE columns and plates combine sorbent wettability with optimized SPE components, allowing better flow consistency and in many cases eliminating the need for SPE column conditioning; thus simplifying and reducing extraction processing. This poster compares the performance of various EVOLUTE EXPRESS column chemistries using 10-500 mg bed weights, in order to investigate whether sorbent conditioning and equilibration steps are truly required.
Part No: P064Issued year: 2014File size: 0.47mbFile type: pdf
This poster presents a simple method for the extraction and subsequent detection of both the traditional hydroxy metabolites and the biologically active dihydroxy metabolites in serum. High analyte recoveries and low ion suppression were demonstrated, allowing limits of quantitation at low pg/mL levels for the di-OH metabolites and < 1 ng/mL levels for the OH metabolites.
Part No: P156Issued year: 2017File size: 0.23mbFile type: pdf
Most drugs are excreted in urine as glucuronide conjugates. Hydrolysis using a beta-glucuronidase enzyme to convert the metabolites to their “free” form for analysis increases sensitivity. Red abalone (Kura Biotech), abalone (Campbell Scientific), and recombinant (IMCSzyme) beta-glucuronidase enzymes were evaluated to determine which provided the most complete hydrolysis of glucuronide metabolites without effecting the overall recovery of non-conjugated compounds.
EVOLUTE EXPRESS CX 96-well plates were used to extract hydrolysed urine samples, and the impact of th enzymes was compared.
MSACL 2017, Palm Springs
SOFT 2017, Boca Raton
Part No: TN-31.0712Issued year: 2012File size: 0.93mbFile type: pdf
EXPRESS represents a leap forward in high
throughput solid phase extraction. The EVOLUTE
EXPRESS range of 96-well SPE plates combines
powerful EVOLUTE sorbent chemistry with innovative
features that enhance productivity by optimizing
or even eliminating the need for some traditional
steps in the SPE procedure. By truly eliminating the
need for conditioning and equilibration, samples
can be prepared by loading the plate, washing away
interferences and eluting with compatible solvents
EVOLUTE® EXPRESS Solid Phase Extraction products
from Biotage are designed for all your sample
preparation challenges. Whether you are working in the field of bio-analysis during drug development, clinical or forensic
toxicology, or with the diversity of samples in food
safety and environmental applications, the tools and
methods used for sample preparation have a clear
impact on productivity. This user guide contains information about choosing the correct EVOLUTE EXPRESS product for your application and optimizing your methodology for best results.
Part No: TN-0012.0610Issued year: 2010File size: 0.38mbFile type: pdf
Through innovative patented technology molecularly
imprinted polymers (MIPs) can afford improved clean-up in
your processes. Unwanted contaminants or high value
desirables can be efficiently extracted from processes
streams, resulting in more efficient production and cleaner
Part No: AN717Issued year: 2010File size: 0.48mbFile type: pdf
Pharmaceutical companies and those who supply them with intermediates, constantly strive to produce API’s and
intermediates of the highest purity. At the same time, many established production facilities face strong competitive
pressures to produce high quality product at lower costs. Drug substance impurities are wide-ranging as described in the
International Conference on Harmonization (ICH) “Impurities in new Drug Substances”1. Of particular concern in recent
years are the ‘genotoxic compounds.
Part No: P128v2Issued year: 2016File size: 0.4mbFile type: pdf
This poster discusses various stages of the sample preparation process to determine and assess the potential for cross contamination and present approaches to minimize and or eliminate the effect.